Laser Therapy Shows Promise in Brain Cancer Treatment
September 8, 2026 — Discover how laser therapy is improving brain cancer outcomes, with insights from Washington University and CNS Pharmaceuticals. Learn about LITT and its potential.
Curated Health Wellness News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
Ocumetics Begins Patient Recruitment for Group Two Clinical Study
September 8, 2026 — Ocumetics starts patient recruitment for Group Two trial of its accommodating IOL, evaluating safety and vision performance. Learn about the next step in this vision tech.
Quantum BioPharma's Lucid-MS Receives FDA Clearance for Phase 2 MS Trial
September 8, 2026 — Quantum BioPharma's Lucid-MS gets FDA clearance for Phase 2 trial in progressive MS. First-in-class drug aims to repair myelin, offering new hope for patients.
NanoViricides' Ebola Drug Trial Registered in Africa, Dosing Imminent
September 8, 2026 — NanoViricides' Ebola drug trial registered in Africa, dosing imminent. Phase II study of NV-387 Oral Gummies may offer new treatment for Ebola and Mpox.
Nutriband Receives USPTO Notice for Trademarks on Abuse-Deterrent Fentanyl Patch
September 8, 2026 — Nutriband gets USPTO Notice of Publication for trademarks on its abuse-deterrent fentanyl patch with AVERSA technology, a step toward US market entry.
Quantum BioPharma's Lucid-MS Gets FDA Nod for Phase 2 MS Trial
September 8, 2026 — Quantum BioPharma gets FDA clearance for phase 2 trial of Lucid-MS in multiple sclerosis. Rodman & Renshaw initiates coverage with Buy rating and $8 target.
Quantum BioPharma's Lucid-MS Gets FDA Nod for Phase 2 MS Trial
September 8, 2026 — Quantum BioPharma's Lucid-MS gets FDA clearance for Phase 2 MS trial, targeting demyelination. A potential breakthrough in multiple sclerosis treatment.
Quantum BioPharma's Lucid-MS Gets FDA Nod for Phase 2 MS Trial
September 8, 2026 — Quantum BioPharma's Lucid-MS gets FDA clearance to start Phase 2 trial for multiple sclerosis. First-in-class PAD2 inhibitor targets demyelination. Learn more.
Tonix Pharmaceuticals Promotes Thomas Englese to Chief Commercial Officer
September 8, 2026 — Tonix Pharmaceuticals promotes Thomas Englese to CCO to lead commercialization of TONMYA for fibromyalgia, expanding patient access and driving growth.
Grizzly Attack and Cancer Survivor Launches BRYTR DAYS Nutrition Drink
September 8, 2026 — Survivor of grizzly attack and Stage 4 cancer launches BRYTR DAYS, a once-daily nutritional drink for real life. Learn how the Three Rs shape its formula.
AcroMeta Partners to Revolutionize Cell Logistics with ATCLS Technology
September 8, 2026 — AcroMeta Group acquires stake in Macro-ATCLS to bring ambient temperature cellular logistics to Southeast Asia, targeting a US$14.5B market by 2032.
Flu Season Precautions: Expert Advice on Vaccination and Prevention
September 8, 2026 — Get expert tips on flu prevention from Dr. Matthew Heller, including the importance of the flu shot, hygiene practices, and who should seek care. Stay healthy this season.
Youth Tobacco Use Hits Historic Low Amid Adult Smoking Concerns
September 8, 2026 — Discover how youth tobacco use has reached historic lows while FDA authorizes ZYN nicotine pouches for adult smokers seeking reduced-risk alternatives. Learn about PMI's prevention strategies and the impact on public health.
Affordable Dental Implants in Denton: Quality Without Compromise
September 7, 2026 — Learn how to find affordable dental implants in Denton without sacrificing quality. Compare providers, understand costs, check insurance, and explore financing options.
Kind Smiles Irvine Adds Pediatric Airway Orthodontics & Assessment
September 6, 2026 — Kind Smiles Orthodontics in Irvine, CA now offers pediatric airway orthodontics and airway assessment for children and teens in Orange County. Learn more.
How to Save on Dental Implants Without Sacrificing Quality
September 5, 2026 — Discover how to get affordable dental implants without compromising quality. Learn cost-saving tips, financing options, and how to compare providers in Dallas.
Six Attorneys Named Finalists for 2026 Consumer Attorney of the Year
September 5, 2026 — Six Stebner Gertler & Guadagni attorneys are finalists for CAOC's 2026 Consumer Attorney of the Year for their role in a landmark elder neglect case that led to legal reforms.
AOM Capital Provides $3.8M Bridge Loan to Healthcare Firm
September 4, 2026 — AOM Capital provides $3.8M bridge financing to a Northeastern healthcare company to bridge reimbursement delays. This deal highlights specialty lending solutions in healthcare.
Nanox Expands U.S. Reach with New England Distribution Agreement
September 4, 2026 — Nanox partners with Associated X-Ray Imaging to distribute Nanox.ARC in New England, expanding access to 3D tomosynthesis technology for preventive care.
Timing of Brain Metastases Predicts Colorectal Cancer Survival
September 4, 2026 — A study of 5,617 colorectal cancer patients reveals that timing of brain metastases impacts survival. Learn how this could guide treatment and drug development.